Cat. No. | Product Name / Activity |
---|---|
1701 | A 77636 hydrochloride |
Potent and selective D1-like agonist; orally active | |
1702 | N6-Cyclopentyladenosine |
Potent and selective A1 agonist | |
1704 | Ionomycin calcium salt |
Calcium ionophore | |
1705 | 2-Chloro-N6-cyclopentyladenosine |
Potent and selective A1 agonist | |
1706 | Acetaminophen |
Cyclooxygenase inhibitor; may be selective for COX-3 | |
1708 | Indomethacin |
Cyclooxygenase inhibitor (COX-1 > COX-2) | |
1709 | CL 218872 |
Benzodiazepine agonist | |
1710 | CV 1808 |
Non-selective adenosine A2 receptor agonist | |
1742 | R-96544 hydrochloride |
Potent, selective 5-HT2A antagonist | |
1743 | Bay 11-7085 |
Irreversible inhibitor of TNF-α-induced IκBα phosphorylation | |
1744 | Bay 11-7821 |
E2 ubiquitin (Ub) conjugating enzymes inhibitor | |
1745 | 5-Iodotubercidin |
Potent adenosine kinase inhibitor; also inhibits nucleoside transporters and a range of other kinases | |
1746 | Nemonapride |
Highly potent D2-like antagonist; also 5-HT1A agonist | |
1747 | Isoproterenol hydrochloride |
Standard selective β agonist | |
1748 | MG 132 |
Proteasome and calpain inhibitor. Inhibits NF-κB activation | |
1749 | HexylHIBO |
Group I mGlu antagonist | |
1757 | ALX 5407 hydrochloride |
Selective non-transportable GlyT1 inhibitor | |
1758 | PETCM |
Activator of caspase-3 | |
1760 | (±)-Blebbistatin |
Selective inhibitor of myosin II ATPase activity | |
1761 | Baicalein |
5- and 12-Lipoxygenase inhibitor | |
1762 | Acifran |
Hypolipidemic agent; agonist for the GPR109A (HM74A) and GPR109B receptors | |
1763 | BAM (8-22) |
Potent MRGPRX1 agonist | |
1764 | Hemopressin (rat) |
Selective CB1 inverse agonist | |
1766 | UBP 301 |
Kainate antagonist | |
1768 | Fumagillin |
Methionine aminopeptidase-2 inhibitor; antiangiogenic | |
1769 | Flurbiprofen |
Cyclooxygenase inhibitor | |
1771 | S 14506 hydrochloride |
Highly potent 5-HT1A agonist; displays unique binding mechanism | |
1772 | Urapidil hydrochloride |
α1 antagonist; also 5-HT1A receptor agonist | |
1774 | Dynamin inhibitory peptide |
Dynamin inhibitor | |
1775 | Dynamin inhibitory peptide, myristoylated |
Cell-permeable dynamin inhibitor | |
1776 | Dynamin inhibitory peptide, myristoylated (control) |
Control peptide version of dynamin inhibitory peptide, myristoylated (Cat. No. 1775) | |
1777 | Arctigenin |
Potent MEK1 inhibitor. Also inhibits IκBα phosphorylation | |
1778 | Ro 106-9920 |
Inhibitor of NF-κB activation | |
1779 | NNC 711 |
Selective GAT-1 inhibitor | |
1780 | NNC 63-0532 |
Potent non-peptide NOP agonist; brain penetrant | |
1784 | Spantide I |
Selective NK1 antagonist | |
1785 | Bax inhibitor peptide V5 |
Inhibitor of Bax-mediated apoptosis | |
1788 | GRP (porcine) |
Endogenous GRP receptor agonist | |
1789 | GRP (human) |
Endogenous GRP receptor agonist | |
1790 | Pseudo RACK1 |
Protein kinase C activator peptide (attached to cell permeable vector) | |
1791 | PKC ζ pseudosubstrate |
PKC ζ inhibitor peptide (attached to cell-permeable vector) | |
1792 | PKC β pseudosubstrate |
Selective cell-permeable PKC inhibitor peptide (attached to vector) | |
1793 | AF 12198 |
Potent, selective human type I IL-1 receptor antagonist | |
1795 | Zacopride hydrochloride |
Highly potent 5-HT3 antagonist; also 5-HT4 agonist | |
1797 | OMDM-2 |
Potent inhibitor of anandamide uptake | |
1798 | Gabexate mesylate |
Serine protease inhibitor; inhibits thrombin, trypsin, kallikrein and plasmin | |
1799 | WKYMVM |
Selective FPR2 and FPR3 receptor agonist |